JP2004528316A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528316A5
JP2004528316A5 JP2002576888A JP2002576888A JP2004528316A5 JP 2004528316 A5 JP2004528316 A5 JP 2004528316A5 JP 2002576888 A JP2002576888 A JP 2002576888A JP 2002576888 A JP2002576888 A JP 2002576888A JP 2004528316 A5 JP2004528316 A5 JP 2004528316A5
Authority
JP
Japan
Prior art keywords
agent
cytotoxic agent
therapeutic agent
cancer therapeutic
rarα
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002576888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528316A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/008718 external-priority patent/WO2002078620A2/en
Publication of JP2004528316A publication Critical patent/JP2004528316A/ja
Publication of JP2004528316A5 publication Critical patent/JP2004528316A5/ja
Withdrawn legal-status Critical Current

Links

JP2002576888A 2001-03-22 2002-03-22 癌治療のための、レチノイド受容体リガンドおよび選択される細胞毒性剤の相乗的な組み合わせ Withdrawn JP2004528316A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27775401P 2001-03-22 2001-03-22
PCT/US2002/008718 WO2002078620A2 (en) 2001-03-22 2002-03-22 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer

Publications (2)

Publication Number Publication Date
JP2004528316A JP2004528316A (ja) 2004-09-16
JP2004528316A5 true JP2004528316A5 (https=) 2005-12-22

Family

ID=23062213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002576888A Withdrawn JP2004528316A (ja) 2001-03-22 2002-03-22 癌治療のための、レチノイド受容体リガンドおよび選択される細胞毒性剤の相乗的な組み合わせ

Country Status (15)

Country Link
EP (1) EP1383491A2 (https=)
JP (1) JP2004528316A (https=)
KR (1) KR20030086314A (https=)
CN (1) CN1498105A (https=)
BR (1) BR0207681A (https=)
CA (1) CA2441335A1 (https=)
CZ (1) CZ20032540A3 (https=)
DE (1) DE02733871T1 (https=)
ES (1) ES2214985T1 (https=)
HU (1) HUP0400255A2 (https=)
IL (1) IL157358A0 (https=)
MX (1) MXPA03008403A (https=)
PL (1) PL368946A1 (https=)
TR (1) TR200400812T3 (https=)
WO (1) WO2002078620A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5113038B2 (ja) * 2006-03-23 2013-01-09 テムリック株式会社 癌治療用キットおよび癌治療用医薬組成物

Similar Documents

Publication Publication Date Title
JP2021063088A5 (https=)
JP2005525345A5 (https=)
JP2011528713A5 (https=)
JP2009535352A5 (https=)
EP2248519A3 (en) Non-mucoadhesive film dosage forms
JP2010077141A5 (https=)
JP2015512406A5 (https=)
JP2005518413A5 (https=)
JP2020097577A5 (https=)
JP2006504795A5 (https=)
JP2009502743A5 (https=)
JP2005515966A5 (https=)
JP2004509061A5 (https=)
JP2013507439A5 (https=)
JP2004519469A5 (https=)
JP2013508279A5 (https=)
JP2012525393A5 (https=)
JP2020512337A5 (https=)
JP2019515908A5 (https=)
RU2005126412A (ru) Сор1 для лечения воспалительных заболеваний кишечника
JP2007520452A5 (https=)
JP2008534453A5 (https=)
JP2006518731A5 (https=)
CA2648518A1 (en) Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
JP2007506801A5 (https=)